Opinion

Video

Devices for Control of Motor Symptoms in PD

Author(s):

Zoltan Mari, MD, reviews the available wearable devices used to monitor bradykinesia and dyskinesia in patients with PD, as well as benefits and challenges associated with the devices.

This is a video synopsis/summary of a panel discussion involving Zoltan Mari, MD.

The speaker discusses the complexities of monitoring symptoms in Parkinson's disease and the array of devices available for this purpose. While numerous technologies exist, each with its benefits and challenges, the effectiveness of any measurement depends on its relevance to the individual patient's clinical context. Dyskinesia, for instance, can be objectively tracked by various devices, but its significance varies from patient to patient.

Despite the objective nature of these measurements, their interpretation still relies on clinical judgment. Patients may not always accurately perceive their symptoms, leading to discrepancies between subjective and objective assessments. For instance, a patient may exhibit visible dyskinesias in the clinic without perceiving them as problematic, while another may find them severely debilitating despite similar objective measurements.

Moreover, while the focus of wearable technologies often centers on motor symptoms, Parkinson's disease encompasses various non-motor symptoms that significantly impact patients' quality of life. Efforts to incorporate these aspects into monitoring, such as tracking sleep quality and overall well-being, are underway but still require development.

Ultimately, the decision to utilize objective monitoring devices hinges on their relevance to individual patient care and the broader clinical context. While advancements in technology offer valuable insights into Parkinson's disease management, a holistic approach that considers both motor and non-motor symptoms is essential for comprehensive patient care.

Video synopsis is AI-generated and reviewed by NeurologyLive editorial staff.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.